News & Press
Latest news
Company newsMay 30, 2025Press Release: Positive Clinical Trial Results for Cerebri for Migraine Prevention
Oslo, Norway – May 30, 2025 – Nordic Brain Tech, a leader in neurotechnology and digital therapeutics, today announced positive results from a randomized controlled trial evaluating Cerebri, its novel app- and sensor-based therapy for the preventive treatment of migraine.
Brain TwinMay 23, 2025Brain Twin Integrated in Electronic Health Record
Brain Twin is now available for primary care providers in Norway
Company newsMay 21, 2025Nordic Brain Tech Featured in Expert Panel at LSX Nordic Congress
For the first time, the LSX Nordic Congress took place in Norway, gathering innovators, investors, and thought leaders in life sciences and digital health.
Press
“Researchers predict migraines with help of AI”, in Dagens Medisin
A recent pilot study by the Norwegian Center for Headache Research (NorHead) has demonstrated the potential of artificial intelligence (AI) to predict migraine attacks.
Featured by DNB as a Promising HealthTech Investment Opportunity
DNB has spotlighted Nordic Brain Tech in their recent coverage from the Nordic Healthcare Conference, highlighting the company’s cutting-edge approach to migraine prevention and its active search for strategic investors.
“Prevent migraine attacks without medication”, in Forskning.no
In a recent feature on Forskning.no, Nordic Brain Tech’s innovative migraine prevention app was spotlighted for its ability to reduce migraine attacks without the use of medication.
"App for Migraine", in Gemini
"Norway needs a reimbursement scheme for digital therapy", in Medwatch
"Fighting back against headaches", in Dagens Næringsliv
"Used AI to predict migraine", in Gemini
"From headache to entrepreneurs", in Finansavisen
"investigates whether AI can predict migraine", in Forskning.no
“We must reduce the disease burden caused by migraines", in Dagens Medisin
Expanding Brain Twin, featured in Shifter
"Norwegian app can give less migraines", in Teknisk Ukeblad
All articles
- Company newsMay 30, 2025
Press Release: Positive Clinical Trial Results for Cerebri for Migraine Prevention
Oslo, Norway – May 30, 2025 – Nordic Brain Tech, a leader in neurotechnology and digital therapeutics, today announced positive results from a randomized controlled trial evaluating Cerebri, its novel app- and sensor-based therapy for the preventive treatment of migraine.
- Brain TwinMay 23, 2025
Brain Twin Integrated in Electronic Health Record
Brain Twin is now available for primary care providers in Norway
- Company newsMay 21, 2025
Nordic Brain Tech Featured in Expert Panel at LSX Nordic Congress
For the first time, the LSX Nordic Congress took place in Norway, gathering innovators, investors, and thought leaders in life sciences and digital health.
Company newsMay 20, 2025The Healthtech Festival 2025
Showcasing the Future of Digital Migraine Care at The Healthtech Festival 2025
CenliMay 07, 2025Introducing Cenli – Making advanced biofeedback accessible
The team behind the upcoming medical product Cerebri is now launching Cenli – a new home-based biofeedback tool that helps users regulate stress and train their nervous system, with no need for medical supervision.
Brain TwinApril 30, 2025Brain Twin strengthens its market position with new doctor dashboard
Patients can now securely share their headache data with doctors – the first step in our plan to build a powerful clinical platform.
Company newsMarch 26, 2025Nordic Brain Tech presenting at Nordic-American Healthcare Conference in New York
Through the Healthcare Innovation Accelerator, Nordic Brain Tech was selected to present in the early stage pitch session among 8 Norwegian companies
CerebriMarch 07, 2025Jenny Nesje recognized among Norway's 50 Leading Women in Tech
When Jenny Nesje joined Nordic Brain Tech (NBT), she set out to demonstrate that advanced medical technology for migraine care could be developed and clinically validated in Norway.
CerebriDecember 05, 2024Presentation at the 18th European Headache Congress
The BioCer clinical trial has reached a major milestone with the completion of its primary phase.
Company newsNovember 26, 2024Nordic Brain Tech selected as 1 of 8 companies in health tech accelerator
The market entry program gives a unique opportunity to meet with investors and prepare for the U.S. market
Brain TwinNovember 08, 2024Nordic Brain Tech and Pfizer Finland has launched Brain Twin in a partnership
With Brain Twin, Finland's first migraine app in Finnish, Pfizer can revolutionize migraine care with cutting-edge technology.
Brain TwinNovember 04, 2024Introducing Calmer: The breathing pacer for migraine relief and stress reduction
Calmer offers a simple yet powerful way to help you relax, de-stress, and soothe your nervous system through guided breathing exercises making you feel.. Calmer!